Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

被引：0
|
作者：
A. N. Aravindan
Venkatesh Moger
Vinay Sakhuja
Harbir S. Kohli
Neelam Varma
Vivekanand Jha
机构：
[1] Postgraduate Institute of Medical Education and Research,Departments of Nephrology
[2] Hematology,undefined
[3] Postgraduate Institute of Medical Education and Research,undefined
来源：
International Urology and Nephrology | 2006年 / 38卷
关键词：
Kidney transplantation; Posttransplant lymphoproliferative disorder; Hepatitis C; Immunosuppression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Posttransplant lymphoproliferative disorders (PTLD) are commonly caused by Ebstein-Barr Virus infection. The role of hepatitis C virus (HCV) in the genesis of lymphomas has been recognized recently. We report a HCV infected renal transplant recipient who developed PTLD 11 months after transplantation. Reduction of immunosuppression led to disappearance of viremia and clearance of PTLD. This is the first such report in the world literature.
引用
下载
收藏
页码：355 / 357
页数：2
相关论文
共 50 条
  • [1] Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient
    Aravindan, A. N.
    Moger, Venkatesh
    Sakhuja, Vinay
    Kohli, Harbir S.
    Varma, Neelam
    Jha, Vivekanand
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (02) : 355 - 357
  • [2] Hepatitis C virus infection in the renal transplant recipient
    First, MR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 60 - 64
  • [3] Rejection Versus Posttransplantation Lymphoproliferative Disorder in a Renal Transplant Recipient
    Troxell, Megan L.
    Dunlap, Jennifer B.
    Mittalhenkle, Anuja
    Ishag, Mona
    Fan, Guang
    Huang, James Z.
    Gatter, Ken
    Byrd, Dan M.
    Webster, Devon
    Houghton, Donald C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) : 1174 - 1179
  • [4] Posttransplant Lymphoproliferative Disorder With Lung Involvement in a Renal Transplant Recipient
    Mirza, Emel Isiktas
    Mutluay, Ruya
    Suyani, Elif
    Okyay, Gulay Ulusal
    Akyurek, Nalan
    Aki, Sahika Zeynep
    Derici, Ulver
    Arinsoy, Turgay
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (06) : 425 - 428
  • [5] Clinical impact of hepatitis C virus infection in the renal transplant recipient
    Kallinowski, B
    Hergesell, O
    Zeier, M
    NEPHRON, 2002, 91 (04) : 541 - 546
  • [6] Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder in a Renal Transplant Recipient Treated with Tacrolimus and Antithymocyte Globulin
    Agnes L. F. Chan
    Hue-Yu Wang
    Clinical Drug Investigation, 2003, 23 : 281 - 283
  • [7] Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a renal transplant recipient treated with tacrolimus and antithymocyte globulin
    Chan, ALF
    Wang, HY
    CLINICAL DRUG INVESTIGATION, 2003, 23 (04) : 281 - 283
  • [8] Lymphoproliferative disorder in a lung transplant recipient
    Haji, Hassan A.
    Corwin, Douglas S.
    So, Jennifer Y.
    Reed, Robert M.
    BMJ CASE REPORTS, 2020, 13 (03)
  • [9] Posttransplant Lymphoproliferative disorder followed by Hodgkins disease in a renal transplant recipient
    Lokare, Anand
    Chaganti, Sridhar
    Lipkin, Graham
    Roberts, Claudia
    Mahendra, Prem
    TRANSPLANTATION, 2008, 85 (08) : 1219 - 1220
  • [10] Tuberculosis and hepatitis C virus coinfection in a renal transplant recipient: A therapeutic challenge
    Jayaprakash, V
    Rathoon, Ajay
    Gupta, Rishabh
    Sreedhar, S.
    INDIAN JOURNAL OF TRANSPLANTATION, 2023, 17 (02) : 268 - 269
12345